Wird geladen...

Ocular Pharmacokinetics of a Novel Loteprednol Etabonate 0.4% Ophthalmic Formulation

INTRODUCTION: Topical ophthalmic formulations of corticosteroids are commonly used to treat a variety of ocular diseases and conditions that have an inflammatory component. The purpose of this study was to evaluate the effect of the mucus-penetrating particle (MPP) technology on the pharmacokinetic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmol Ther
Hauptverfasser: Schopf, Lisa, Enlow, Elizabeth, Popov, Alexey, Bourassa, James, Chen, Hongming
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Healthcare 2014
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4254862/
https://ncbi.nlm.nih.gov/pubmed/25134493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-014-0021-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!